Global provider of eCOA solutions

Supporting sponsors, pharmaceutical companies, biotechnology companies and CROs, we aim to improve clinical trials with intuitive and innovative electronic Clinical Outcome Assessment (eCOA) solutions, for better data quality and trial efficiency.

Global solutions for supervised
and unsupervised eCOA

We offer a wide range of eCOA solutions to fit each study and therapeutic area. Our devices are designed to improve clinical trial compliance and reduce data capture errors with intuitive, efficient and user-friendly eCOA solutions for patients. With safe and real-time data capture, patients and sponsors fully benefit from the advantages of electronic solutions, adapted to both supervised and unsupervised clinical studies.

Committed to improve
the quality of clinical studies

Over 10 years of global eCOA experience has allowed us to build powerful tools and services that help sponsors to collect complete, accurate and reliable data.

Improving patient engagement
Patient engagement is key to increasing both the quantity and quality of clinical trials data while ensuring compliance regarding taking the clinical trial drug(s), filling diaries, and remaining actively involved in the trial.
This increase in quality generates overall savings in the budget for the trial while at the same time increasing relevant data collection.

Read more

Latest news

  • 2018 Employee Satisfaction Survey

    The results are in! 2018 was marked by… | Read More

  • aligning objectives ecoa vendor
    The benefits & practicalities of aligning the objectives of an eCOA vendor with those of the study

    Any enduring business relationship between a service provider… | Read More

  • Inclusion and gender diversity is not a given!

    This can only be the result of a… | Read More

  • Including eCOA in a clinical trial in China

    With a large patient pool and growing pharma… | Read More

  • Kayentis supports the 1st personalized immunotherapy treatment approved by both FDA & CHMP

    Acute Lymphoblastic or Lymphoid Leukemia (ALL) is a… | Read More


  • 22 October
    OCT Nordics - Oct 22&23 - Copenhagen, Denmark - Booth #10 - Schedule a meeting with Kayentis
  • 10 November
    DIA Japan 2019 - Nov 10-12 - Tokyo Big Sight, Ariake - Booth #42 -  Schedule a meeting with Kayentis
  • 19 November
    AG DMB - Nov 19 - Paris, France - Booth #14 - Schedule a meeting with Kayentis
  • 19 November
    Clinical Trials Europe - Nov 19-21 - Barcelona, Spain - Booth #51 - Schedule a meeting with Kayentis   Clinical Trials Europe
  • 06 May
    OCT Europe 2020 - May 6-7 - Paris, France - Booth #83 - Schedule a meeting with Kayentis
  • Linkedin updates

      LinkedIn Company Updates

    • Sorry, no posts were received from LinkedIn!